Researcher
Armand Van Deun
- Keywords:B230-bacteriology, B680-public-health, B725-diagnostics, B726-clinical-biology
Affiliations
- Mycobacteriology (Research unit)
Member
From31 Dec 1998 → 29 Nov 2018 - Mycobacteriology (Research unit)
Member
From31 Dec 1998 → 16 Apr 2015
Projects
1 - 4 of 4
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
- Significance of initial isoniazid resistance for outcome of standard TB treatment and its detection by line-probe assaysFrom1 Jan 2018 → 31 Dec 2018
- Trend of fluoroquinolone resistance among the MDR in DF BangladeshFrom1 Jan 2017 → 31 Dec 2018
- Validity and feasability of use of a rapid and innovative test for detection of Multi Drug Resistant (MDR) TB cases in Kinshasa, DRCFrom1 Mar 2009 → 6 Jul 2018
Publications
21 - 30 of 142
- Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis(2021)
Authors: Tom Decroo, Kya Jai, Kya Jai Maug Aung, Mohamed Anwar Hossain, M Gumusboga, Nimer Ortuno-Gutierrez, Bouke de Jong, Armand Van Deun
- High-dose first-line treatment regimen for recurrent rifampicin-susceptible tuberculosis(2020)
Authors: Tom Decroo, Bouke de Jong, Alberto Piubello, Mahamadou Bassirou Souleymane, Lutgarde Lynen, A Van Deun
Pages: 1578-1579 - First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Authors: A.K.J. Maug, M.A. Hossain, M Gumusboga, Tom Decroo, W Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pages: 499-505 - Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali(2020)
Authors: Bassirou Diarra, Tom Decroo, Amadou Somboro, G. Coulibaly, Mohamed Tolofoudie, M. Kone, Boureima Degoga, F. Diallo, A C G Togo, M. Sanogo, et al.
Pages: 763-769 - Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda(2020)
Authors: Jean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, Yves Mucyo Habimana, Armand Van Deun, Conor J. Meehan, Gabriela Torrea, Faridath Massou, Willem Bram de Rijk, Bertin Ushizimpumu, et al.
Pages: E74-E83 - Case report: dynamics of acquired fluoroquinolone resistance under standardized short-course treatment of multidrug-resistant tuberculosis(2020)
Authors: Jean Claude Semuto Ngabonziza, A Van Deun, Patrick Migambi, Niyigena Esdras Belamo, Dusabe Théogène, Yves Mucyo Habimana, Bertin Ushizimpumu, W Mulders, Tom Decroo, Dissou Affolabi, et al.
Pages: 1443-1446 - The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance(2020)
Authors: Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Murid Gumusboga, W Mulders, Nimer Ortuno-Gutierrez, Lutgarde Lynen, Bouke de Jong, Hans L. Rieder
- Management of falsepositive rifampicin resistant Xpert MTB/RIF - Authors' reply(2020)
Authors: Jean Claude Semuto Ngabonziza, Tom Decroo, Gabriela Torrea, Patrick Migambi, A Van Deun, L Rigouts, Bouke de Jong
Pages: e239 - Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda(2020)
Authors: Jean Claude Semuto Ngabonziza, M. Y. Habimana, Tom Decroo, P. Migambi, Augustin Dushime, Jean-Baptiste Mazarati, L Rigouts, D Affolabi, Emil Ivan, Conor J. Meehan, et al.
Pages: 329-339 - Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: nationwide programmatic achievements(2020)
Authors: Alberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, Abdourahamane Yacouba, Pauline Lempens, Mourtala Mohamed Assao-Neino, Ibrahim Maman-Lawan, Sala Attaher, Boubacar Moustapha, Alphazazi Soumana, et al.